Blockade of STUB1 in T cells boosts anti-tumor immunity. Study from the #SharpeLab led by @martinlafleur.bsky.social & #LaurenMilling @natimmunol.nature.com.
@genelayinstitute.bsky.social @harvardmed.bsky.social @broadinstitute.org
hms.harvard.edu/news/researc...
www.nature.com/articles/s41...
@genelayinstitute.bsky.social @harvardmed.bsky.social @broadinstitute.org
hms.harvard.edu/news/researc...
www.nature.com/articles/s41...
Research Identifies New Ways To Supercharge Cancer Immunotherapy
Findings, based on mouse studies, could pave the way for more effective cancer treatments
hms.harvard.edu
August 18, 2025 at 11:46 PM
Blockade of STUB1 in T cells boosts anti-tumor immunity. Study from the #SharpeLab led by @martinlafleur.bsky.social & #LaurenMilling @natimmunol.nature.com.
@genelayinstitute.bsky.social @harvardmed.bsky.social @broadinstitute.org
hms.harvard.edu/news/researc...
www.nature.com/articles/s41...
@genelayinstitute.bsky.social @harvardmed.bsky.social @broadinstitute.org
hms.harvard.edu/news/researc...
www.nature.com/articles/s41...